The relationship between hs-CRP and asthma control test in asthmatic patients

Allergologia et Immunopathologia

Volumn 40, Issue 6, 2012, Pages 362-367

  Kilic, Hatice ^a   Karalezli, Aysegul ^a   Hasanoglu, H Canan ^a   Erel, Ozcan ^a   Ates, Can ^b  

^a Ataturk Hospital   (Turkey)

^b Biostatistics Department   (Turkey)

Author keywords

Asthma; Asthma control; Asthma control test; Asthma severity; CRP; Hs CRP; Inflammation; Prognosis; Respiratory function tests

Indexed keywords

C REACTIVE PROTEIN; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; ASTHMA CONTROL TEST; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; PHYSICIAN; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ASTHMA; C-REACTIVE PROTEIN; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RESPIRATORY FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84869109294     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2011.10.002     Document Type: Article

References (36)

1. Sahoo R.C., Acharya P.R., Noushad T.H., Anand R., Acharya V.K., Sahu K.R. A study of high-sensitivity C-reactive protein in bronchial asthma. Indian J Chest Dis Allied Sci 2009, 51:215.
2. Pepys M.B., Batz M.L. Acute phase protein with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid a protein. Adv Immunol 1983, 34:141-212.
3. Anderson G.P. COPD, asthma and C-reactive protein. Eur Respir J 2006, 27:874-876.
4. Pepys M.B., Hirshfield G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
5. Aziz N., Fahey J.L., Detels R., Butch A.W. Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood. Clin Diagn Lab Immunol 2003, 10:652-657.
6. Bassuk S.S., Rifai N., Ridker P.M. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004, 29:439-493.
7. Tilemanna L., Gindnerb L., Meyerc F., Szecsenyib J., Schneidera A. Research paper differences in local and systemic inflammatory markers in patients with obstructive airways disease. Prim Care Respir J 2011, 20:407-414.
8. Elbehidy R.M., Amr G.E., Radwan H.M. High sensitivity-C reactive protein as a novel marker for airway inflammation and steroid responsiveness in asthmatic children. Egypt J Bronchol 2010, 4:79-87.
9. Kony S., Zureik M., Driss F. Association of bronchial hyper responsiveness and lung function with C-reactive protein (crp): a population based study. Thorax 2004, 59:892-896.
10. Navratil M., Plavec D., Dodig S. Markers of systemic and lung inflammation in childhood asthma. J Asthma 2009, 46:822-828.
11. Tracy R.P. Inflammation in cardiovascular disease: cat, horse, or both?. Circulation 1998, 97:2000-2002.
12. Rifai N., Tracy R.P., Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999, 45:2136-2141.
13. Roberts W.L., Sedrick R., Moulton L., Spencer A., Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 2000, 46:461-468.
14. Roberts Wl., Moulton L., Law T.C. Evaluation of nine automated high sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 2001, 47:418-425.
15. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
16. Global Initiative For Asthma (GINA). Global Strategy For Asthma Management And Prevention. Nhlbi/Who Workshop Report. National Institute Of Health. National Heart, Lung And Blood Institute. Revised 2007.
17. Nathan R.A., Sorkness C.A., Kosinski M., Schatz M., Li J.T., Marcus P., et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004, 113:59-65.
18. Takemura M., Matsumoto H., Niimi A., Ueda T., Matsuoka H. High sensitivity C-reactive protein in asthma. Eur Respir J 2006, 27:908-912.
19. Bochner B.S., Busse W.W. Allergy and asthma. J Allergy Clin Immunol 2005, 115:953-959.
20. Joppa P., Petrasova D., Stancak B., Tkacova R. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 2006, 130:326-333.
21. Malo O., Sauleda J., Busquets X., Miralles C., Agusti A. Systemic inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 2002, 38:172-176.
22. Qian F.H., Zhang Q., Zhou L.F., Liu H., Huang M., Zhang X.L., et al. High-sensitivity C-reactive protein: a predictive marker in severe asthma. Respirology 2008, 13:664-669.
23. Sävykoski T., Harju T., Paldanius M., Kuitunen H., Bloigu A. Chlamydia pneumoniae infection and inflammation in adults with asthma. Respiration 2004, 71:120-125.
24. Pepys M.B., Hirschfield G.M., Tennent G.A., Gallimore J.R., Kahan M.C. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006, 440:1217-1221.
25. Ballou S.P., Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992, 4:361-368.
26. Tillie-Leblond I., Montani D., Crestani B., De Blic J., Humbert M., De-Lara T., et al. Relation between inflammation and symptoms in asthma. Allergy 2009, 64:354-367.
27. Giannini D., Di Franco A., Cianchetti S., Bacci E., Dente Fl, Vagaggini B., et al. Analysis of induced sputum before and after withdrawal of treatment with inhaled corticosteroids in asthmatic patients. Clin Exp Allergy 2000, 30:1777-1784.
28. Büyüköztürk S., Gelincik A.A., Genç S., Koçak H., Oneriyidogan Y., Erden S., et al. Acute phase reactants in allergic airway disease. Tohoku J Exp Med 2004, 204:209-213.
29. Ramirez D., Patel P., Casillas A., Cotelingam J., Boggs P., Bahna S.L. Assessment of high-sensitivity C-reactive protein as a marker of airway inflammation in asthma. Ann Allergy Asthma Immunol 2010, 104:485-489.
30. Fujita M., Ueki S., Ito W., Chiba T., Takeda M. C-reactive protein levels in the serum of asthmatic patients. Ann Allergy Asthma Immunol 2007, 99:48-53.
31. Kim M.H., Kim S.H., Kang H.R., Park H.W., Chang Y.S., Kim D.H., et al. High-sensitivity C-reactive protein as a marker of bronchial hyperresponsiveness and lung function. J Asthma Allergy Clin Immunol 2009, 29:112-116.
32. Kony S., Zureik M., Driss F., Neukirch C., Leynaert B., Neukirch F. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (Crp): a population based study. Thorax 2004, 59:892-896.
33. Qlafsdottir I.S., Gislason T., Thjodleifsson B., Olafsson I., Gislasondet A. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005, 60:451-454.
34. Lonnkvist K., Hellman C., Lundahl J., Hallden G., Hedlin G. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of Budesonide treatment and withdrawal. J Allergy Clin Immunol 2001, 107:812-817.
35. Rytila P., Metso T., Heikkinen K., Saarelainen P., Helenius I.J., Haahtela T. Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Eur Respir J 2000, 16:824-830.
36. Juniper E.F., Burst A.S., Cox F.M., Ferrie P.S., Leing D.R. Validation of a standardized version of Quality Of Life Questionnaire. Chest 1999, 115:1265-1270.